Pharmacokinetics of anti-tuberculosis drugs in children

Indian Journal of Pediatrics

Volumn 78, Issue 4, 2011, Pages 435-442

  Ramachandran, Geetha ^a   Kumar, A K Hemanth ^a   Swaminathan, Soumya ^a,b  

^a INDIAN COUNCIL OF MEDICAL RESEARCH   (India)

^b UNICEF   (United States)

Author keywords

Children; Pharmacokinetics; TB

Indexed keywords

DRUG METABOLIZING ENZYME; ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; TUBERCULOSTATIC AGENT;

AGE DISTRIBUTION; AREA UNDER THE CURVE; ARTICLE; BODY WEIGHT; CHILD; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DISPOSITION; DRUG EFFICACY; DRUG RESPONSE; DRUG TISSUE LEVEL; EXTRAPULMONARY TUBERCULOSIS; GENETIC POLYMORPHISM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAXIMUM PLASMA CONCENTRATION; MEDLINE; NUTRITIONAL STATUS; OPTIMAL DRUG DOSE; PHARMACOGENETICS; RECOMMENDED DRUG DOSE; SYSTEMATIC REVIEW; TREATMENT DURATION; TREATMENT OUTCOME; TUBERCULOSIS;

AGE FACTORS; ANTITUBERCULAR AGENTS; CHILD; GENOTYPE; HIV INFECTIONS; HUMANS; NUTRITIONAL STATUS;

EID: 79954446375     PISSN: 00195456     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12098-010-0304-x     Document Type: Article

References (51)

1. Global tuberculosis control-epidemiology, strategy, financing. WHO report 2009. http://www.who.int/tb/publications/global-report/2009/en/index.html. Accessed on 9 August 2010.
2. World Health Organisation. Guidance for national tuberculosis programmes on the management of tuberculosis in children. Geneva: World Health Organisation; 2006.
3. National tuberculosis control program practical guidelines 2000. Pretoria, South Africa: Department of health, Republic of South Africa, 2000. Available at: http://www.doh.gov.za/tb/index.html (Under resources: Basic documents and reports). Accessed on 18 August 2010.
4. HS Schaaf DP Parkin HI Seifart, et al. 2005 Isoniazid pharmacokinetics in children treated for respiratory tuberculosis Arch Dis Child 90 614 8 15908628 10.1136/adc.2004.052175 1:STN:280:DC%2BD2M3msFKjsQ%3D%3D (Pubitemid 40780724)
5. S Thee A Detjen U Wahn K Magdorf 2010 Isoniazid pharmacokinetic studies of the 1960s: considering a higher isoniazid dose in childhood tuberculosis Scand J Infect Dis 42 294 8 20100111 10.3109/00365540903493731 1:CAS:528:DC%2BC3cXjtFKitb0%3D
6. H Mcllleron M Willemse CJ Werely, et al. 2009 Isoniazid plasma concentrations in a cohort of South African children with tuberculosis: implications for international pediatric dosing guidelines Clin Infect Dis 48 1547 53 10.1086/598192
7. S Thee A Detjen U Wahn K Magdorf 2009 Rifampicin serum levels in childhood tuberculosis Int J Tuberc Lung Dis 13 1106 11 19723399 1:STN:280:DC%2BD1MrpslWgug%3D%3D
8. HS Schaaf M Willemse K Cilliers, et al. 2009 Rifampin pharmacokinetics in children, with and without human immunodeficiency virus infection, hospitalised for the management of severe forms of tuberculosis BMC Med 7 19 29 19386087 10.1186/1741-7015-7-19
9. Ramachandran G, Hemanth Kumar AK, Sekar L, et al. Influence of age and nutritional status on the pharmacokinetics of anti-tuberculosis drugs in children with tuberculosis. In: Abstract book; 3rd International Workshop on Clinical Pharmacology of tuberculosis drugs, September 2010 (Abstract # O-09). Available at: www.virology-education.com. Accessed on 18 September 2010.
10. PR Donald D Maher JS Maritz S Qazi 2006 Ethambutol dosage for the treatment of children: literature review and recommendations Int J Tuberc Lung Dis 10 1318 30 17167947 1:STN:280:DC%2BD28jjtVWjtQ%3D%3D (Pubitemid 44929444)
11. SM Graham DJ Bell S Nyirongo R Hartkoorn SA Ward EM Molyneux 2006 Low levels of pyrazinamide and ethambutol in children with tuberculosis and impact of age, nutritional status, and human immunodeficiency virus infection Antimicrob Agents Chemother 50 407 13 16436690 10.1128/AAC.50.2.407-413.2006 1:CAS:528:DC%2BD28XhsFegtr0%3D (Pubitemid 43190946)
12. JR King DW Kimberlin GM Aldrovandi EP Acosta 2002 Antiretroviral pharmacokinetics in the pediatric population-A review Clin Pharmacokinet 41 1115 33 12405863 10.2165/00003088-200241140-00001 1:CAS:528:DC%2BD38XpsFKmsbk%3D (Pubitemid 35398689)
13. FS Al Dossary LT Ong AG Correa, et al. 2002 Treatment of childhood tuberculosis with a 6 month directly observed regimen of only 2 weeks of daily therapy Pediatr Infect Dis J 21 91 7 10.1097/00006454-200202000-00002 (Pubitemid 34150604)
14. S Swaminathan 2000 Treatment of tuberculosis Indian J Pediatr 67 S14 20 11129902 10.1007/BF02802626 1:STN:280:DC%2BD3M7ksVOktQ%3D%3D
15. PM Jeena P Pillay T Pillay HM Coovadia 2002 Impact of HIV -1 co-infection on presentation and hospital-related mortality in children with culture proven pulmonary tuberculosis in Durban, South Africa Int J Tuberc Lung Dis 6 672 8 12150478 1:STN:280:DC%2BD38vgtFOisg%3D%3D (Pubitemid 34832146)
16. N Cranswick K Mulholland 2005 Isoniazid treatment of children: can genetics help guide treatment? Arch Dis Child 90 551 3 15908610 10.1136/adc.2004.063610 1:STN:280:DC%2BD2M3msFGrtw%3D%3D (Pubitemid 40780706)
17. M Weiner C Peloquin W Burman, et al. 2010 Effects of tuberculosis, race and human gene SLCO1B1 polymorphisms on rifampin concentrations Antimicrob Agents Chemother 54 4192 200 20660695 10.1128/AAC.00353-10 1:CAS:528: DC%2BC3cXhtlegtr7F
18. Chigutsa E, Visser ME, Egan D, et al. Population pharmacokinetics of rifampicin in South African tuberculosis patients and the influence of drug transporter polymorphisms. In: Abstract book; 3rd International Workshop on Clinical Pharmacology of tuberculosis drugs, September 2010 (Abstract # O-07). Available at: www.virology-education.com. Accessed on 18 September 2010.
19. CA Peloquin R Namdar MD Singleton DE Nix 1999 Pharmacokinetics of rifampin under fasting conditions, with food, and with antacids Chest 155 12 8 10.1378/chest.115.1.12 (Pubitemid 29047048)
20. Acocella G, Buniva G, Flauto U, Nicolis FB. Absorption and elimination of the antibiotic rifampicin in newborns and children. In: Proceedings of the sixth international congress of chemotherapy 1969; Tokyo Volume 2. Tokyo: University of Tokyo Press; 1970. pp. 755-760.
21. Mcllleron H, Rustomjee R, Vahedi M, et al. Weight and sex are important determinants of antituberculosis drug concentrations in patients with HIV associated tuberculosis. In: Abstract book; 3rd International Workshop on Clinical Pharmacology of tuberculosis drugs, September 2010 (Abstract # O-10). Available at: www.virology-education.com. Accessed on 18 September 2010.
22. Hall RG, Meek C, Swancutt MGT, Lee R. A surprising effect of weight on ethambutol pharmacokinetics. In: Abstract book; 3rd International Workshop on Clinical Pharmacology of tuberculosis drugs, September 2010 (Abstract # O-12). Available at: www.virology-education.com. Accessed on 18 September 2010.
23. MY Lin SJ Lin LC Chan YC Lu 2010 Impact of food and antacids on the pharmacokinetics of anti-tuberculosis drugs: systematic review and meta-analysis Int J Tuberc Lung Dis 14 806 18 20550762
24. K Polasa K Krishnaswamy 1986 Rifampicin (600 mg) kinetics in the undernourished Indian J Med Res 83 175 8 3710544 1:STN:280:DyaL283it1Giuw%3D%3D (Pubitemid 16029078)
25. GL Kearns SM Abdel-Rahman SW Alander DL Blowey JS Leeder RE Kauffman 2003 Developmental pharmacology-drug disposition, action and therapy in infants and adults N Engl J Med 349 1157 67 13679531 10.1056/NEJMra035092 1:CAS:528:DC%2BD3sXnsV2jtbo%3D (Pubitemid 37122329)
26. S Thee A Detjen U Wahn K Magdorf 2008 Pyrazinamide serum levels in childhood tuberculosis Int J Tuberc Lung Dis 12 1099 101 18713511 1:STN:280:DC%2BD1crjsFSnsA%3D%3D
27. H Hussels U Kroening K Magdorf 1973 Ethambutol and rifampicin serum levels in children: second report on the combined administration of ethambutol and rifampicin Pneumonologie 149 31 8 4779981 10.1007/BF02179950 1:STN:280:DyaE2c7gsFOmuw%3D%3D
28. GH McCracken CM Ginsburg TC Zweighaft J Clahsen 1980 Pharmacokinetics of rifampin in infants and children: relevance to prophylaxis against Haemophilus influenzae type B disease Pediatrics 66 17 21 6967586 (Pubitemid 10033797)
29. Zvada SP, Simonsson USH, Denti P, et al. Population pharmacokinetics of rifampicin in childhood tuberculosis and the need for dose adjustment. In: Abstract book; 3rd International Workshop on Clinical Pharmacology of tuberculosis drugs, September 2010 (Abstract # O-11). Available at: www.virology-education.com. Accessed on 18 September 2010.
30. M Zhu JR Starke WJ Burman, et al. 2002 Population pharmacokinetic modelling of pyrazinamide in children and adults with tuberculosis Pharmacotherapy 22 686 95 12066959 10.1592/phco.22.9.686.34067 1:CAS:528:DC%2BD38XltFarsrs%3D (Pubitemid 34596476)
31. MW Zhu J Burman JR Starke, et al. 2004 Pharmacokinetics of ethambutol in children and adults with tuberculosis Int J Tuberc Lung Dis 8 1360 7 15581206 1:STN:280:DC%2BD2cngslKntA%3D%3D (Pubitemid 39611583)
32. DS Arya SK Ojha 2009 Pharmacokinetics of pyrazinamide in paediatric patients of tuberculosis meningitis World J Med Sci 4 128 34 1:CAS:528:DC%2BC3cXht1SmsrfM
33. V Roy U Tekur K Chopra 1999 Pharmacokinetics of pyrazinamide in children suffering from pulmonary tuberculosis Int J Tuberc Lung Dis 3 133 7 10091878 1:STN:280:DyaK1M7ptVaquw%3D%3D (Pubitemid 29151816)
34. S Thee A Detjen D Quarcoo U Wahn K Magdorf 2007 Ethambutol in paediatric tuberculosis: aspects of ethambutol serum concentration, efficacy and toxicity in children Int J Tuberc Lung Dis 11 965 71 17705973 1:STN:280: DC%2BD2svoslOntA%3D%3D (Pubitemid 47425022)
35. V Seth A Beotra SD Seth, et al. 1993 Serum concentrations of rifampicin and isoniazid in tuberculosis Indian Pediatr 30 1091 8 8125594 1:STN:280:DyaK2c7ntFemtQ%3D%3D (Pubitemid 23296039)
36. M Mahajan D Rohatgi V Talwar SK Patni P Mahajan DS Agarwal 1997 Serum and cerebrospinal fluid concentrations of rifampicin at two dose levels in children with tuberculous meningitis J Commun Dis 29 269 74 9465533 1:STN:280: DyaK1c7is1Krsw%3D%3D (Pubitemid 127517797)
37. V Roy U Tekur K Chopra 1996 Pharmacokinetics of isoniazid in pulmonary tuberculosis-a comparative study at two dose levels Indian Pediatr 33 287 91 8772902 1:STN:280:DyaK28zmvVyqtg%3D%3D (Pubitemid 126477078)
38. PR Donald 2007 The assessment of new anti-tuberculosis drugs for a pediatric indication Int J Tuberc Lung Dis 11 1162 5 17958976 1:STN:280:DC%2BD2sjgs1yjug%3D%3D (Pubitemid 350146295)
39. KC Chang CC Leung WW Yew, et al. 2008 Peak plasma rifampicin level in tuberculosis patients with slow culture conversion Eur J Clin Microbiol Infect Dis 27 467 72 18214560 10.1007/s10096-007-0454-6 1:CAS:528:DC%2BD1cXlvFajtrk%3D (Pubitemid 351713064)
40. MW Long DR Snider Jr LS Farer 1979 US public health service cooperative trial of three rifampicin-isoniazid regimens in treatment of pulmonary tuberculosis Am Rev Respir Dis 119 879 94 110184 1:STN:280:DyaE1M3gslKjug%3D%3D (Pubitemid 9208241)
41. P Nahid LC Gonzalez I Rudoy, et al. 2007 Treatment outcomes of patients with HIV and tuberculosis Am J Respir Crit Care Med 175 1199 206 17290042 10.1164/rccm.200509-1529OC (Pubitemid 46855463)
42. S Mehta 1990 Malnutrition and drugs: clinical implications Dev Pharmacol Ther 15 159 65 2129200 1:CAS:528:DyaK3MXkt1Wmur0%3D
43. K Krishnaswamy 1989 Drug metabolism and pharmacokinetics in malnourished children Clin Pharmacokinet 17 68 88 2692941 10.2165/00003088-198900171-00006 (Pubitemid 20013418)
44. M Vijayakumar P Bhaskaram P Hemalatha 1990 Malnutrition and childhood tuberculosis J Trop Paediatr 36 294 8 1:STN:280:DyaK3M7isVCqug%3D%3D
45. M Eriksson P Bolme D Habte L Paalzow 1988 INH and streptomycin in Ethiopian children with tuberculosis and different nutritional status Acta Paediatr Scand 77 890 4 3144828 10.1111/j.1651-2227.1988.tb10774.x 1:STN:280:DyaL1M%2Fos1SmsA%3D%3D (Pubitemid 19008622)
46. HI Seifart PR Donald JN de Villiers DP Parkin PP Jaarsveld 1995 Isoniazid elimination kinetics in children with protein-energy malnutrition treated for tuberculous meningitis with a four-component antimicrobial regimen Ann Trop Paediatr 15 249 54 8534045 1:STN:280:DyaK28%2Fpt1Omug%3D%3D
47. DV Havlir PF Barnes 1999 Tuberculosis in patients with human immunodeficiency virus infection N Engl J Med 340 367 73 9929528 10.1056/NEJM199902043400507 1:STN:280:DyaK1M7hvFWksg%3D%3D (Pubitemid 29090803)
48. S Swaminathan CN Deivanayagam S Rajasekaran, et al. 2008 Long term follow up of HIV-infected patients with tuberculosis treated with 6-month intermittent short course chemotherapy Natl Med J India 21 3 7 18472696
49. FA Khan J Minion M Pai, et al. 2010 Treatment of active tuberculosis in HIV-coinfected patients: a systematic review and meta-analysis Clin Infect Dis 50 1288 99 20353364 10.1086/651686
50. B Rekha S Swaminathan 2007 Childhood tuberculosis-global epidemiology and the impact of HIV Paediatr Respir Rev 8 99 106 17574153 10.1016/j.prrv.2007.04. 010 (Pubitemid 46900103)
51. P Gurumurthy G Ramachandran AK Hemanth Kumar, et al. 2004 Decreased bioavailability of rifampin and other anti-TB drugs in patients with advanced HIV disease Antimicrob Agents Chemother 48 4473 5 15504887 10.1128/AAC.48.11. 4473-4475.2004 1:CAS:528:DC%2BD2cXpvVyktLo%3D (Pubitemid 39434921)